Showing results (1801-1810 of 3,475) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|March 15, 2017
Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic DataChristoph P Hornik, Huali Wu, Andrea N Edginton, et al.Clinical Pharmacokinetics|March 15, 2017
Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform LabellingNeeraj Gupta, Paul M Diderichsen, Michael J Hanley, et al.Clinical Pharmacokinetics|October 5, 2019
Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney DiseaseNelleke Snelder, Roland Heinig, Henk-Jan Drenth, et al.Clinical Pharmacokinetics|October 6, 2019
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial RevisitedAmina Bensalem, Denis Mulleman, Gilles Paintaud, et al.Clinical Pharmacokinetics|December 1, 1988
Clinical pharmacokinetics of valproic acid--1988G Zaccara, A Messori, F MoroniClinical Pharmacokinetics|August 22, 2019
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer SubjectsCarlos Pérez-Ruixo, Jonás Samuel Pérez-Blanco, Caly Chien, et al.Clinical Pharmacokinetics|August 22, 2019
Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status AsthmaticusNienke J Vet, Brenda C M de Winter, Muriel Koninckx, et al.Clinical Pharmacokinetics|August 22, 2019
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.Clinical Pharmacokinetics|December 17, 2003
Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agentsHideki Hirabayashi, Jiro FujisakiClinical Pharmacokinetics|December 17, 2003
Role of orphan nuclear receptors in the regulation of drug-metabolising enzymesHongbing Wang, Edward L LeCluysePageof 348